{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T01:15:08Z","timestamp":1789089308525,"version":"build-2803163510"},"reference-count":85,"publisher":"MDPI AG","issue":"5","license":[{"start":{"date-parts":[[2025,5,5]],"date-time":"2025-05-05T00:00:00Z","timestamp":1746403200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Ministry of Defense","award":["4441137465"],"award-info":[{"award-number":["4441137465"]}]},{"name":"Ministry of Defense","award":["000598"],"award-info":[{"award-number":["000598"]}]},{"name":"Ministry of Innovation, Science and Technology","award":["4441137465"],"award-info":[{"award-number":["4441137465"]}]},{"name":"Ministry of Innovation, Science and Technology","award":["000598"],"award-info":[{"award-number":["000598"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmaceutics"],"abstract":"<jats:p>In today\u2019s information-driven era, machine learning is revolutionizing medicinal chemistry, offering a paradigm shift from traditional, intuition-based, and often bias-prone methods to the prediction of chemical properties without prior knowledge of the basic principles governing drug function. This perspective highlights the growing importance of informatics in shaping the field of medicinal chemistry, particularly through the concept of the \u201cinformacophore\u201d. The informacophore refers to the minimal chemical structure, combined with computed molecular descriptors, fingerprints, and machine-learned representations of its structure, that are essential for a molecule to exhibit biological activity. Similar to a skeleton key unlocking multiple locks, the informacophore points to the molecular features that trigger biological responses. By identifying and optimizing informacophores through in-depth analysis of ultra-large datasets of potential lead compounds and automating standard parts in the development process, there will be a significant reduction in biased intuitive decisions, which may lead to systemic errors and a parallel acceleration of drug discovery processes.<\/jats:p>","DOI":"10.3390\/pharmaceutics17050612","type":"journal-article","created":{"date-parts":[[2025,5,5]],"date-time":"2025-05-05T04:31:36Z","timestamp":1746419496000},"page":"612","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["From Patterns to Pills: How Informatics Is Shaping Medicinal Chemistry"],"prefix":"10.3390","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-1133-6711","authenticated-orcid":false,"given":"Alexander","family":"Trachtenberg","sequence":"first","affiliation":[{"name":"Department of Chemistry and Data Science Research Center, Ben-Gurion University of the Negev, Beer-Sheva 8410501, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3882-2742","authenticated-orcid":false,"given":"Barak","family":"Akabayov","sequence":"additional","affiliation":[{"name":"Department of Chemistry and Data Science Research Center, Ben-Gurion University of the Negev, Beer-Sheva 8410501, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,5,5]]},"reference":[{"key":"ref_1","first-page":"59","article-title":"Drug discovery: An appraisal","volume":"7","author":"Umashankar","year":"2015","journal-title":"Int. J. Pharm. Pharm. Sci."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/j.tips.2019.06.004","article-title":"Advancing drug discovery via artificial intelligence","volume":"40","author":"Chan","year":"2019","journal-title":"Trends Pharmacol. Sci."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"148","DOI":"10.3390\/ddc3010009","article-title":"Revolutionizing Drug Discovery: A Comprehensive Review of AI Applications","volume":"3","author":"Dhudum","year":"2024","journal-title":"Drugs Drug Candidates"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"7761","DOI":"10.1038\/s41467-024-52061-7","article-title":"An artificial intelligence accelerated virtual screening platform for drug discovery","volume":"15","author":"Zhou","year":"2024","journal-title":"Nat. Commun."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1038\/nchembio.1197","article-title":"Target validation using chemical probes","volume":"9","author":"Bunnage","year":"2013","journal-title":"Nat. Chem. Biol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1038\/nrd.2017.111","article-title":"Opportunities and challenges in phenotypic drug discovery: An industry perspective","volume":"16","author":"Moffat","year":"2017","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/j.drudis.2018.11.014","article-title":"Artificial intelligence in drug development: Present status and future prospects","volume":"24","author":"Mak","year":"2019","journal-title":"Drug Discov. Today"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1038\/nrd3480","article-title":"How were new medicines discovered?","volume":"10","author":"Swinney","year":"2011","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"e30","DOI":"10.1016\/S0140-6736(20)30304-4","article-title":"Baricitinib as potential treatment for 2019-nCoV acute respiratory disease","volume":"395","author":"Richardson","year":"2020","journal-title":"Lancet"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/j.cell.2020.01.021","article-title":"A deep learning approach to antibiotic discovery","volume":"180","author":"Stokes","year":"2020","journal-title":"Cell"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1038\/s41586-020-2286-9","article-title":"A SARS-CoV-2 protein interaction map reveals targets for drug repurposing","volume":"583","author":"Gordon","year":"2020","journal-title":"Nature"},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Sugiyama, M.G., Cui, H., Redka, D.S., Karimzadeh, M., Rujas, E., Maan, H., Hayat, S., Cheung, K., Misra, R., and McPhee, J.B. (2021). Multiscale interactome analysis coupled with off-target drug predictions reveals drug repurposing candidates for human coronavirus disease. Sci. Rep., 11.","DOI":"10.1038\/s41598-021-02432-7"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1038\/nature09454","article-title":"Clinical efficacy of a RAF inhibitor needs broad target blockade in BRAF-mutant melanoma","volume":"467","author":"Bollag","year":"2010","journal-title":"Nature"},{"key":"ref_14","unstructured":"Poelking, C., Chessari, G., Murray, C.W., Hall, R.J., Colwell, L., and Verdonk, M. (2022). Meaningful machine learning models and machine-learned pharmacophores from fragment screening campaigns. arXiv."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"17744","DOI":"10.1021\/acs.jmedchem.1c01789","article-title":"Explainable machine learning for property predictions in compound optimization: Miniperspective","volume":"64","author":"Bajorath","year":"2021","journal-title":"J. Med. Chem."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Batool, M., Ahmad, B., and Choi, S. (2019). A Structure-Based Drug Discovery Paradigm. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20112783"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.shpsc.2005.07.003","article-title":"Integrating research and development: The emergence of rational drug design in the pharmaceutical industry","volume":"36","author":"Adam","year":"2005","journal-title":"Stud. Hist. Philos. Biol. Biomed. Sci."},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Gambardella, A. (1995). Science and innovation: The US pharmaceutical industry during the 1980s, Cambridge University Press.","DOI":"10.1017\/CBO9780511522031"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"585","DOI":"10.2174\/1389557054023224","article-title":"Structure-activity relationships for the design of small-molecule inhibitors","volume":"5","author":"Andricopulo","year":"2005","journal-title":"Mini Rev. Med. Chem."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1021\/ja02231a009","article-title":"Isomorphism, Isosterism and Covalence","volume":"41","author":"Langmuir","year":"1919","journal-title":"J. Am. Chem. Soc."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Meanwell, N.A. (2021). The Design and Application of Bioisosteres in Drug Design. Burger\u2019s Med. Chem. Drug Discov., 1\u201381.","DOI":"10.1002\/0471266949.bmc259"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1037\/h0030806","article-title":"Human problem solving: The state of the theory in 1970","volume":"26","author":"Simon","year":"1971","journal-title":"Am. Psychol."},{"key":"ref_23","unstructured":"(2025, April 25). Enamine. Available online: https:\/\/enamine.net\/compound-collections\/real-compounds."},{"key":"ref_24","unstructured":"(2025, April 25). CHEMriya. Available online: https:\/\/www.otavachemicals.com\/products\/chemriya."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1038\/nchembio.180","article-title":"Quantifying biogenic bias in screening libraries","volume":"5","author":"Hert","year":"2009","journal-title":"Nat. Chem. Biol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1038\/s41589-022-01234-w","article-title":"Modeling the expansion of virtual screening libraries","volume":"19","author":"Lyu","year":"2023","journal-title":"Nat. Chem. Biol."},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Kahneman, D., and Tversky, A. (2013). Prospect theory: An analysis of decision under risk. Handbook of the Fundamentals of Financial Decision Making: Part I, World Scientific.","DOI":"10.1142\/9789814417358_0006"},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Zhavoronkov, A., Aladinskiy, V., Zhebrak, A., Zagribelnyy, B., Terentiev, V., Bezrukov, D.S., Polykovskiy, D., Shayakhmetov, R., Filimonov, A., and Orekhov, P. (2020). Potential 2019-nCoV 3C-like protease inhibitors designed using generative deep learning approaches. Preprint v2 from ChemRxiv.","DOI":"10.26434\/chemrxiv.11829102.v1"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1038\/194178b0","article-title":"Correlation of biological activity of phenoxyacetic acids with Hammett substituent constants and partition coefficients","volume":"194","author":"Hansch","year":"1962","journal-title":"Nature"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"95","DOI":"10.2174\/156802610790232260","article-title":"3D-QSAR in drug design--a review","volume":"10","author":"Verma","year":"2010","journal-title":"Curr. Top. Med. Chem."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/s41573-023-00832-0","article-title":"Integrating QSAR modelling and deep learning in drug discovery: The emergence of deep QSAR","volume":"23","author":"Tropsha","year":"2024","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Rufa, D.A., Bruce Macdonald, H.E., Fass, J., Wieder, M., Grinaway, P.B., Roitberg, A.E., Isayev, O., and Chodera, J.D. (2020). Towards chemical accuracy for alchemical free energy calculations with hybrid physics-based machine learning\/molecular mechanics potentials. Preprint from BioRxiv.","DOI":"10.1101\/2020.07.29.227959"},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Grisoni, F. (2023). Chemical language models for de novo drug design: Challenges and opportunities. Curr. Opin. Struct. Biol., 79.","DOI":"10.1016\/j.sbi.2023.102527"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1038\/s42004-022-00733-0","article-title":"Generative and reinforcement learning approaches for the automated de novo design of bioactive compounds","volume":"5","author":"Korshunova","year":"2022","journal-title":"Commun. Chem."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/978-1-0716-1787-8_9","article-title":"De Novo Molecular Design with Chemical Language Models","volume":"2390","author":"Grisoni","year":"2022","journal-title":"Methods Mol. Biol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.4155\/fmc-2018-0435","article-title":"Lipophilicity in drug design: An overview of lipophilicity descriptors in 3D-QSAR studies","volume":"11","author":"Ginex","year":"2019","journal-title":"Future. Med. Chem."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1021\/acsomega.2c05607","article-title":"Machine intelligence models for fast, quantum mechanics-based approximation of drug lipophilicity","volume":"8","author":"Lewis","year":"2023","journal-title":"ACS Omega"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.cogdev.2014.12.008","article-title":"Imagination and the generation of new ideas","volume":"34","author":"Magid","year":"2015","journal-title":"Cogn. Dev."},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Wu, Z., Zhu, M., Kang, Y., Leung, E.L., Lei, T., Shen, C., Jiang, D., Wang, Z., Cao, D., and Hou, T. (2021). Do we need different machine learning algorithms for QSAR modeling? A comprehensive assessment of 16 machine learning algorithms on 14 QSAR data sets. Brief. Bioinform., 22.","DOI":"10.1093\/bib\/bbaa321"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1021\/acs.accounts.8b00087","article-title":"Machine Learning in Computer-Aided Synthesis Planning","volume":"51","author":"Coley","year":"2018","journal-title":"Acc. Chem. Res."},{"key":"ref_41","unstructured":"Peeperkorn, M., Brown, D., and Jordanous, A. (2023). On Characterizations of Large Language Models and Creativity Evaluation, University of Kent."},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Visan, A.I., and Negut, I. (2024). Integrating Artificial Intelligence for Drug Discovery in the Context of Revolutionizing Drug Delivery. Life, 14.","DOI":"10.3390\/life14020233"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1111\/cbdd.14262","article-title":"Explainability and white box in drug discovery","volume":"102","author":"Kirboga","year":"2023","journal-title":"Chem. Biol. Drug Des."},{"key":"ref_44","first-page":"80","article-title":"Ethical Considerations Emerge from Artificial Intelligence (AI) in Biotechnology","volume":"17","author":"Dara","year":"2025","journal-title":"Avicenna J. Med. Biotechnol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"e26870","DOI":"10.1002\/qua.26870","article-title":"Molecular representations for machine learning applications in chemistry","volume":"122","author":"Raghunathan","year":"2022","journal-title":"Int. J. Quantum Chem."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1007\/s12293-024-00414-6","article-title":"Molecular representations in bio-cheminformatics","volume":"16","author":"Harvey","year":"2024","journal-title":"Memet. Comput."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s13321-022-00583-x","article-title":"Machine learning approaches to optimize small-molecule inhibitors for RNA targeting","volume":"14","author":"Grimberg","year":"2022","journal-title":"J. Cheminform."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"8764","DOI":"10.1039\/C9SC02520K","article-title":"Discovery of small-molecule inhibitors targeting the ribosomal peptidyl transferase center (PTC) of M. tuberculosis","volume":"10","author":"Tam","year":"2019","journal-title":"Chem. Sci."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1631\/FITEE.1700808","article-title":"Visual interpretability for deep learning: A survey","volume":"19","author":"Zhang","year":"2018","journal-title":"Front. Inf. Technol. Electron. Eng."},{"key":"ref_50","unstructured":"Wang, Y., Zhang, T., Guo, X., and Shen, Z. (2024). Gradient based feature attribution in explainable ai: A technical review. arXiv."},{"key":"ref_51","doi-asserted-by":"crossref","unstructured":"Samek, W., Montavon, G., Vedaldi, A., Hansen, L.K., and M\u00fcller, K.-R. (2019). The (Un)reliability of Saliency Methods. Explainable AI: Interpreting, Explaining and Visualizing Deep Learning, Springer International Publishing.","DOI":"10.1007\/978-3-030-28954-6"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"e1637","DOI":"10.1002\/wcms.1637","article-title":"Efficient and enhanced sampling of drug-like chemical space for virtual screening and molecular design using modern machine learning methods","volume":"13","author":"Goel","year":"2023","journal-title":"Wiley Interdiscip. Rev. Comput. Mol. Sci."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1021\/ar500432k","article-title":"The chemical space project","volume":"48","author":"Reymond","year":"2015","journal-title":"Acc. Chem. Res."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1038\/nature03192","article-title":"Chemical space and biology","volume":"432","author":"Dobson","year":"2004","journal-title":"Nature"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1021\/cn3000422","article-title":"Exploring chemical space for drug discovery using the chemical universe database","volume":"3","author":"Reymond","year":"2012","journal-title":"ACS Chem. Neurosci."},{"key":"ref_56","doi-asserted-by":"crossref","unstructured":"Li, Q. (2020). Application of Fragment-Based Drug Discovery to Versatile Targets. Front. Mol. Biosci., 7.","DOI":"10.3389\/fmolb.2020.00180"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"4990","DOI":"10.1021\/bi3005126","article-title":"Fragment-based approaches in drug discovery and chemical biology","volume":"51","author":"Scott","year":"2012","journal-title":"Biochemistry"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/S1359-6446(04)03069-7","article-title":"Ligand efficiency: A useful metric for lead selection","volume":"9","author":"Hopkins","year":"2004","journal-title":"Drug Discov. Today"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/S1359-6446(05)03386-6","article-title":"Ligand efficiency indices as guideposts for drug discovery","volume":"10","author":"Metz","year":"2005","journal-title":"Drug Discov. Today"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1038\/nrd.2016.109","article-title":"Twenty years on: The impact of fragments on drug discovery","volume":"15","author":"Erlanson","year":"2016","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1038\/nchem.217","article-title":"The rise of fragment-based drug discovery","volume":"1","author":"Murray","year":"2009","journal-title":"Nat. Chem."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.pbiomolbio.2014.09.007","article-title":"Efficient exploration of chemical space by fragment-based screening","volume":"116","author":"Hall","year":"2014","journal-title":"Prog. Biophys. Mol. Biol."},{"key":"ref_63","doi-asserted-by":"crossref","unstructured":"Singh, M., Tam, B., and Akabayov, B. (2018). NMR-Fragment Based Virtual Screening: A Brief Overview. Molecules, 23.","DOI":"10.3390\/molecules23020233"},{"key":"ref_64","first-page":"e47486","article-title":"Artificial Intelligence\u2019s Impact on Drug Discovery and Development From Bench to Bedside","volume":"15","author":"Vidhya","year":"2023","journal-title":"Cureus"},{"key":"ref_65","doi-asserted-by":"crossref","unstructured":"Sanchez-Lengeling, B., Outeiral, C., Guimaraes, G.L., and Aspuru-Guzik, A. (2017). Optimizing distributions over molecular space. An objective-reinforced generative adversarial network for inverse-design chemistry (ORGANIC). ChemRxiv.","DOI":"10.26434\/chemrxiv.5309668.v2"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1126\/science.aat2663","article-title":"Inverse molecular design using machine learning: Generative models for matter engineering","volume":"361","year":"2018","journal-title":"Science"},{"key":"ref_67","doi-asserted-by":"crossref","unstructured":"Menacer, R., Bouchekioua, S., Meliani, S., and Belattar, N. (2024). New combined Inverse-QSAR and molecular docking method for scaffold-based drug discovery. Comput. Biol. Med., 180.","DOI":"10.1016\/j.compbiomed.2024.108992"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1016\/j.drudis.2018.01.039","article-title":"The rise of deep learning in drug discovery","volume":"23","author":"Chen","year":"2018","journal-title":"Drug Discov. Today"},{"key":"ref_69","doi-asserted-by":"crossref","unstructured":"Polykovskiy, D., Zhebrak, A., Sanchez-Lengeling, B., Golovanov, S., Tatanov, O., Belyaev, S., Kurbanov, R., Artamonov, A., Aladinskiy, V., and Veselov, M. (2020). Molecular Sets (MOSES): A Benchmarking Platform for Molecular Generation Models. Front. Pharmacol., 11.","DOI":"10.3389\/fphar.2020.565644"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1021\/acs.jcim.8b00839","article-title":"GuacaMol: Benchmarking Models for de Novo Molecular Design","volume":"59","author":"Brown","year":"2019","journal-title":"J. Chem. Inf. Model."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1758-2946-1-8","article-title":"Estimation of synthetic accessibility score of drug-like molecules based on molecular complexity and fragment contributions","volume":"1","author":"Ertl","year":"2009","journal-title":"J. Cheminform."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"3339","DOI":"10.1039\/D0SC05401A","article-title":"Retrosynthetic accessibility score (RAscore)\u2014Rapid machine learned synthesizability classification from AI driven retrosynthetic planning","volume":"12","author":"Thakkar","year":"2021","journal-title":"Chem. Sci."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s13321-023-00711-1","article-title":"MolFilterGAN: A progressively augmented generative adversarial network for triaging AI-designed molecules","volume":"15","author":"Liu","year":"2023","journal-title":"J. Cheminform."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"3679","DOI":"10.1021\/acs.jpca.0c00042","article-title":"Simpler is Better: How Linear Prediction Tasks Improve Transfer Learning in Chemical Autoencoders","volume":"124","author":"Iovanac","year":"2020","journal-title":"J. Phys. Chem. A"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1021\/acscentsci.7b00572","article-title":"Automatic Chemical Design Using a Data-Driven Continuous Representation of Molecules","volume":"4","author":"Wei","year":"2018","journal-title":"ACS Cent. Sci."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"3098","DOI":"10.1021\/acs.molpharmaceut.7b00346","article-title":"druGAN: An Advanced Generative Adversarial Autoencoder Model for de Novo Generation of New Molecules with Desired Molecular Properties in Silico","volume":"14","author":"Kadurin","year":"2017","journal-title":"Mol. Pharm."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1038\/s42256-020-0174-5","article-title":"Direct steering of de novo molecular generation with descriptor conditional recurrent neural networks","volume":"2","author":"Kotsias","year":"2020","journal-title":"Nat. Mach. Intell."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1038\/s42256-020-00268-w","article-title":"Reusability report: Designing organic photoelectronic molecules with descriptor conditional recurrent neural networks","volume":"2","author":"Mohapatra","year":"2020","journal-title":"Nat. Mach. Intell."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"305","DOI":"10.4236\/jbise.2021.147026","article-title":"Inverse molecule design with invertible neural networks as generative models","volume":"14","author":"Hu","year":"2021","journal-title":"J. Biomed. Sci. Eng."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1038\/s42256-020-00236-4","article-title":"Drug discovery with explainable artificial intelligence","volume":"2","author":"Grisoni","year":"2020","journal-title":"Nat. Mach. Intell."},{"key":"ref_81","doi-asserted-by":"crossref","unstructured":"Aliferis, C., and Simon, G. (2024). Overfitting, underfitting and general model overconfidence and under-performance pitfalls and best practices in machine learning and AI. Artificial Intelligence and Machine Learning in Health Care and Medical Sciences: Best Practices and Pitfalls, Springer.","DOI":"10.1007\/978-3-031-39355-6_10"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"100686","DOI":"10.1016\/j.modpat.2024.100686","article-title":"Ethical and Bias considerations in artificial intelligence (AI)\/machine learning","volume":"38","author":"Hanna","year":"2024","journal-title":"Mod. Pathol."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.1021\/acs.jcim.2c00224","article-title":"Exploration of Ultralarge Compound Collections for Drug Discovery","volume":"62","author":"Warr","year":"2022","journal-title":"J. Chem. Inf. Model."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"100588","DOI":"10.1016\/j.patter.2022.100588","article-title":"SELFIES and the future of molecular string representations","volume":"3","author":"Krenn","year":"2022","journal-title":"Patterns"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1021\/acs.jcim.8b00825","article-title":"Interpretation of QSAR models by coloring atoms according to changes in predicted activity: How robust is it?","volume":"59","author":"Sheridan","year":"2019","journal-title":"J. Chem. Inf. Model."}],"container-title":["Pharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1999-4923\/17\/5\/612\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T17:27:10Z","timestamp":1760030830000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1999-4923\/17\/5\/612"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,5]]},"references-count":85,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2025,5]]}},"alternative-id":["pharmaceutics17050612"],"URL":"https:\/\/doi.org\/10.3390\/pharmaceutics17050612","relation":{},"ISSN":["1999-4923"],"issn-type":[{"value":"1999-4923","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,5]]}}}